RPRX Long Put Strategy
RPRX (Royalty Pharma plc), in the Healthcare sector, (Medical - Pharmaceuticals industry), listed on NASDAQ.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
RPRX (Royalty Pharma plc) trades in the Healthcare sector, specifically Medical - Pharmaceuticals, with a market capitalization of approximately $24.19B, a trailing P/E of 29.34, a beta of 0.42 versus the broader market, a 52-week range of 34.081-56.5, average daily share volume of 3.7M, a public-listing history dating back to 2020, approximately 100 full-time employees. These structural characteristics shape how RPRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.42 indicates RPRX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. RPRX pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long put on RPRX?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current RPRX snapshot
As of June 30, 2026, spot at $56.39, ATM IV 22.30%, IV rank 9.84%, expected move 6.39%. The long put on RPRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 171-day expiry.
Why this long put structure on RPRX specifically: RPRX IV at 22.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a RPRX long put, with a market-implied 1-standard-deviation move of approximately 6.39% (roughly $3.61 on the underlying). The 171-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RPRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on RPRX should anchor to the underlying notional of $56.39 per share and to the trader's directional view on RPRX stock.
RPRX long put setup
The RPRX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RPRX near $56.39, the first option leg uses a $57.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RPRX chain at a 171-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RPRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $57.50 | $4.25 |
RPRX long put risk and reward
- Net Premium / Debit
- -$425.00
- Max Profit (per contract)
- $5,324.00
- Max Loss (per contract)
- -$425.00
- Breakeven(s)
- $53.25
- Risk / Reward Ratio
- 12.527
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
RPRX long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on RPRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$5,324.00 |
| $12.48 | -77.9% | +$4,077.30 |
| $24.94 | -55.8% | +$2,830.59 |
| $37.41 | -33.7% | +$1,583.89 |
| $49.88 | -11.5% | +$337.19 |
| $62.35 | +10.6% | -$425.00 |
| $74.81 | +32.7% | -$425.00 |
| $87.28 | +54.8% | -$425.00 |
| $99.75 | +76.9% | -$425.00 |
| $112.21 | +99.0% | -$425.00 |
When traders use long put on RPRX
Long puts on RPRX hedge an existing long RPRX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying RPRX exposure being hedged.
RPRX thesis for this long put
The market-implied 1-standard-deviation range for RPRX extends from approximately $52.78 on the downside to $60.00 on the upside. A RPRX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long RPRX position with one put per 100 shares held. Current RPRX IV rank near 9.84% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RPRX at 22.30%. As a Healthcare name, RPRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RPRX-specific events.
RPRX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RPRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RPRX alongside the broader basket even when RPRX-specific fundamentals are unchanged. Long-premium structures like a long put on RPRX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current RPRX chain quotes before placing a trade.
Frequently asked questions
- What is a long put on RPRX?
- A long put on RPRX is the long put strategy applied to RPRX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With RPRX stock trading near $56.39, the strikes shown on this page are snapped to the nearest listed RPRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RPRX long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the RPRX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 22.30%), the computed maximum profit is $5,324.00 per contract and the computed maximum loss is -$425.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RPRX long put?
- The breakeven for the RPRX long put priced on this page is roughly $53.25 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RPRX market-implied 1-standard-deviation expected move is approximately 6.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on RPRX?
- Long puts on RPRX hedge an existing long RPRX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying RPRX exposure being hedged.
- How does current RPRX implied volatility affect this long put?
- RPRX ATM IV is at 22.30% with IV rank near 9.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.